Biosimilar market worth of KRW 63 trillion will be opened

Published: 2014-11-21 13:32:41

Updated: 2014-11-21 13:32:41

It is expected that the biosimilar market will expand within several years due to patent expirations of original drugs. Currently, the international market size of the expired drugs reaches about KRW 63 trillion.

According to the HyundaiSecurities Corporation’s industry analysis report on the 19^th, the Abbvie’s rheumatic arthritis treatment ‘Humira’ will expired on its patent in Europe in Apri...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.